Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Lung Neoplasms 16Small Cell Lung Carcinoma 10Breast Neoplasms 8Esophageal Neoplasms 5Sarcoma 4Neoplasms 4Melanoma 4Colorectal Neoplasms 4Advanced Lung Cancer 4Stomach Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Thoracic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Mesothelioma 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Adenocarcinoma of Lung 2Widespread Small Cell Lung Cancer 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Uncommon Pathological Types of Lung Cancer 1Thyroid Neoplasms 1Testicular Neoplasms 1Squamous Cell Lung Cancer 1

Interventions

Pemetrexed 6Cisplatin 4Carboplatin 4pembrolizumab 3pralsetinib 2osimertinib 2entinostat 2atezolizumab 2Paclitaxel 2130-nm albumin-bound paclitaxel 2trametinib 1siltuximab 1repotrectinib 1ficlatuzumab 1enzalutamide 1durvalumab 1dabrafenib 1cobimetinib 1cemiplimab 1Vemurafenib 1Taxes 1Nivolumab 1Injections 1Gemcitabine 1Gefitinib 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Injections × Thoracic × Clear all
NCT03351842 2017-12-19

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting
460 enrolled
Thoracic

Adenocarcinoma of Lung, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡